GlaxoSmithKline: Rhinitis, Allergic, Seasonal trials
The registry lists 31 Rhinitis, Allergic, Seasonal studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 10 have results posted.
Phase 1 4Phase 2 7Phase 3 10Phase 4 5No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Drug Utilization Study for Pirinase Hayfever ReliefCompletedNCT02856282Results posted
- A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic RhinitisCompletedNCT01916226Phase 4Results posted
- Assessment of Fluticasone Propionate on Ocular Allergy SymptomsCompletedNCT01817790Phase 3Results posted
- 723/726 Proof of Concept Study in Allergen Challenge Chamber in HannoverCompletedNCT00972504Phase 2Results posted
- Comparator Study Evaluating Patient Preference Of FFNS vs. FPNSCompletedNCT00539006Phase 4Results posted
- Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNSCompletedNCT00519636Phase 4Results posted
- Fluticasone Furoate Nasal Spray Versus Oral FexofenadineCompletedNCT00502775Phase 4Results posted
- A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With RhinitisCompletedNCT00464568Phase 2Results posted
- Fluticasone Furoate Nasal Spray Versus Oral FexofenadineCompletedNCT00435461Phase 4Results posted
- Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)CompletedNCT00346775Phase 3Results posted
- Post Marketing Surveillance for Contac Bien Z in JapanCompletedNCT02020902
- An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics.CompletedNCT01480271Phase 1
- Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy SettingTerminatedNCT01337323
- Regulatory AVAMYS Nasal Spray PMSCompletedNCT01001130
- Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With PlaceboCompletedNCT00851344Phase 2
- Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male SubjectsCompletedNCT00694993Phase 1
- A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)CompletedNCT00612820Phase 2
- A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic RhinitisCompletedNCT00612118Phase 2
- Investigation Of a New Oral Anti-Histamine in Healthy Male SubjectsCompletedNCT00605852Phase 1
- A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.CompletedNCT00517946
- Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberCompletedNCT00430157Phase 2
- Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberCompletedNCT00377728Phase 2
- Study of GW685698X In Patients With Seasonal Allergic RhinitisCompletedNCT00363740Phase 3
- Study Of Perennial Allergic RhinitisCompletedNCT00358475Phase 3
- Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)CompletedNCT00348361Phase 1
- Study In Adults And Adolescents With Seasonal Allergic Rhinitis.CompletedNCT00225823Phase 3
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)CompletedNCT00197262Phase 3
- Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of ActionCompletedNCT00118729Phase 3
- Study In Adults And Adolescents With Seasonal Allergic RhinitisCompletedNCT00115622Phase 3
- Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal SprayCompletedNCT00109486Phase 3
- Seasonal Allergic Rhinitis In Pediatric SubjectsCompletedNCT00107757Phase 3